2Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine [J]. Chest, 1992, 101 (6): 1644-1655.
3Kim IB, Fealy N, Baldwin I. Circuit start during continuous renal replacement therapy in vasopressor-dependent patients: The impact of a slow blood flow protocol [J]. Blood Purif, 2011, 32 ( 1 ) : 1-6.
4Ronco C, Bellomo R. Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to nmhiple organ support therapy (MOST) [ J]. Int J Artif Organs, 2002, 25 (8):733-747.
5Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 [J]. Crit Care Med, 2008, 36 (1) : 296327.
6Parakiuinkas D, Greenbaum LA. Comparison of solute clearance in three modes of continuous renal replacement therapy [J]. Pediatr Crit Care Med, 2004 (3) : 269-274.
7Matsumoto K, Hayashi T. Continuous venovenous hcmofiltration (CVVH) therapy in patient with refractory heart failure [ J ]. Nippon Rinsho, 2007, 28 (5) : 255-258.
8de Pont AC, Bouman CS, Bakhtiari K, et al. Predilution versus postdilution during continuous venovenous hemofihration : a comparison of circuit thrombogenesis [ J ]. ASAIO J, 2006, 52 (4) : 416-422.
9Joon-Sung Park, Gheun-Ho Kim, et al. Regional Anticoagulation with citrate is superior to systemic anticoagulation with heparin in Critically Ⅲ patients undergoing continuous venovenous hemodiafihration [J]. Korean J Intern Med, 2011, 26 (1): 68-75.
10Oudemans-van Straaten HM. Citrate anticoagulation for continuous renal replacement therapy in the critically ill [ J ]. Blood Purif, 2010, 29 (2) : 1.91-196.
